Caitong International Asset Management’s Cyclerion Therapeutics CYCN Stock Holding History

Caitong International Asset Management’s Portfolio CYCN Stock Details CYCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$6	–	3090
2026 Q1	$6	Buy	+4	New	+$6	﹤0.01%	2230

Other funds holding CYCN

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Caitong International Asset Management's CYCN Position: Q2 2026 in Review

Caitong International Asset Management sold out of Cyclerion Therapeutics (CYCN) in Q2 2026, closing a stake of 4 shares — an estimated $6 sold.

Caitong International Asset Management first reported a position in CYCN in Q1 2026 and held it in 1 quarter. The position peaked at $6 in Q1 2026. 1 fund tracked by Wall St. Rank holds CYCN as of Q2 2026.

Caitong International Asset Management reported no remaining Cyclerion Therapeutics position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 4 Cyclerion Therapeutics shares in Q2 2026, an estimated $6.
Caitong International Asset Management first reported a position in Cyclerion Therapeutics in Q1 2026 and held it in 1 quarter.
Caitong International Asset Management's Cyclerion Therapeutics position peaked at $6 in Q1 2026.
1 fund tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.